Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colleen R Kelly

Showing results (61-70 of 85) with videos related to

Pageof 9
Sort By:
The American Journal of Gastroenterology|May 18, 2016
Predictors of Early Failure After Fecal Microbiota Transplantation for the Therapy of Clostridium Difficile Infection: A Multicenter StudyMonika Fischer, Dina Kao, Shama R Mehta, et al.
Journal of Clinical Gastroenterology|July 1, 2015
Long-term Follow-up Study of Fecal Microbiota Transplantation for Severe and/or Complicated Clostridium difficile Infection: A Multicenter ExperienceOlga C Aroniadis, Lawrence J Brandt, Adam Greenberg, et al.
The New England Journal of Medicine|October 31, 2019
Donor Screening for Fecal Microbiota TransplantationZain Kassam, Nancy Dubois, Bharat Ramakrishna, et al.
Annals of Internal Medicine|August 23, 2016
Effect of Fecal Microbiota Transplantation on Recurrence in Multiply Recurrent Clostridium difficile Infection: A Randomized TrialColleen R Kelly, Alexander Khoruts, Christopher Staley, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|November 27, 2025
Impact of switching from polymerase chain reaction-only to two-step <i>Clostridioides difficile</i> testing in a large hospital systemSapana R Gupta, Tyler M Selig, Kathryn Evey, et al.
Gastroenterology|November 9, 2021
Donor Screening for Fecal Microbiota Transplantation in China: Evaluation of 8483 CandidatesShaoyi Zhang, Qiyi Chen, Colleen R Kelly, et al.
Gut|April 29, 2025
Translational strategies for oral delivery of faecal microbiota transplantationSrinivas Kamath, Robert V Bryant, Samuel P Costello, et al.
The Lancet. Gastroenterology & Hepatology|March 21, 2020
Screening of faecal microbiota transplant donors during the COVID-19 outbreak: suggestions for urgent updates from an international expert panelGianluca Ianiro, Benjamin H Mullish, Colleen R Kelly, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 7, 2026
Mirikizumab Long-Term Efficacy and Safety in Patients with Crohn's disease: Results from the VIVID-2 Open-Label Extension TrialBruce E Sands, Edward L Barnes, Geert D'Haens, et al.
The Journal of Infectious Diseases|February 25, 2016
A Novel Microbiome Therapeutic Increases Gut Microbial Diversity and Prevents Recurrent Clostridium difficile InfectionSahil Khanna, Darrell S Pardi, Colleen R Kelly, et al.
Pageof 9

Showing results (61-70 of 85) with videos related to

Sort By:
Pageof 9
The American Journal of Gastroenterology|May 18, 2016
Predictors of Early Failure After Fecal Microbiota Transplantation for the Therapy of Clostridium Difficile Infection: A Multicenter StudyMonika Fischer, Dina Kao, Shama R Mehta, et al.
Journal of Clinical Gastroenterology|July 1, 2015
Long-term Follow-up Study of Fecal Microbiota Transplantation for Severe and/or Complicated Clostridium difficile Infection: A Multicenter ExperienceOlga C Aroniadis, Lawrence J Brandt, Adam Greenberg, et al.
The New England Journal of Medicine|October 31, 2019
Donor Screening for Fecal Microbiota TransplantationZain Kassam, Nancy Dubois, Bharat Ramakrishna, et al.
Annals of Internal Medicine|August 23, 2016
Effect of Fecal Microbiota Transplantation on Recurrence in Multiply Recurrent Clostridium difficile Infection: A Randomized TrialColleen R Kelly, Alexander Khoruts, Christopher Staley, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|November 27, 2025
Impact of switching from polymerase chain reaction-only to two-step <i>Clostridioides difficile</i> testing in a large hospital systemSapana R Gupta, Tyler M Selig, Kathryn Evey, et al.
Gastroenterology|November 9, 2021
Donor Screening for Fecal Microbiota Transplantation in China: Evaluation of 8483 CandidatesShaoyi Zhang, Qiyi Chen, Colleen R Kelly, et al.
Gut|April 29, 2025
Translational strategies for oral delivery of faecal microbiota transplantationSrinivas Kamath, Robert V Bryant, Samuel P Costello, et al.
The Lancet. Gastroenterology & Hepatology|March 21, 2020
Screening of faecal microbiota transplant donors during the COVID-19 outbreak: suggestions for urgent updates from an international expert panelGianluca Ianiro, Benjamin H Mullish, Colleen R Kelly, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 7, 2026
Mirikizumab Long-Term Efficacy and Safety in Patients with Crohn's disease: Results from the VIVID-2 Open-Label Extension TrialBruce E Sands, Edward L Barnes, Geert D'Haens, et al.
The Journal of Infectious Diseases|February 25, 2016
A Novel Microbiome Therapeutic Increases Gut Microbial Diversity and Prevents Recurrent Clostridium difficile InfectionSahil Khanna, Darrell S Pardi, Colleen R Kelly, et al.
Pageof 9